PubRank

Carolyn J Anderson

Author PubWeight™ 76.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. J Med Chem 2004 3.57
2 Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chem Rev 2010 2.70
3 Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands. J Med Chem 2002 1.92
4 Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator. Clin Cancer Res 2004 1.89
5 Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proc Natl Acad Sci U S A 2009 1.72
6 Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET). Acc Chem Res 2009 1.49
7 Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64. Nat Protoc 2006 1.42
8 Synthesis and characterization of a macrocyclic near-infrared optical scaffold. J Am Chem Soc 2003 1.33
9 Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors. Cancer Biother Radiopharm 2008 1.30
10 Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents. J Med Chem 2007 1.30
11 In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy. J Nucl Med 2003 1.22
12 The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals. J Nucl Med 2013 1.22
13 (64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity. Nucl Med Biol 2009 1.14
14 Optimization of labeling and metabolite analysis of copper-64-labeled azamacrocyclic chelators by radio-LC-MS. Nucl Med Biol 2005 1.14
15 Evaluation of multivalent, functional polymeric nanoparticles for imaging applications. ACS Nano 2011 1.13
16 Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptide. J Nucl Med 2007 1.10
17 Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant arms. Dalton Trans 2011 1.10
18 Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors. J Nucl Med 2008 1.10
19 Agonist-antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor. Bioconjug Chem 2007 1.09
20 Correlating EGFR expression with receptor-binding properties and internalization of 64Cu-DOTA-cetuximab in 5 cervical cancer cell lines. J Nucl Med 2008 1.07
21 DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy. Bioconjug Chem 2002 1.07
22 Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator. Bioconjug Chem 2012 1.03
23 A new phosphonate pendant-armed cross-bridged tetraamine chelator accelerates copper(ii) binding for radiopharmaceutical applications. Dalton Trans 2009 1.03
24 Subcellular localization of radiolabeled somatostatin analogues: implications for targeted radiotherapy of cancer. Cancer Res 2003 1.01
25 Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities. Curr Pharm Des 2008 1.00
26 Comparative uptakes and biodistributions of internalizing vs. noninternalizing copper-64 radioimmunoconjugates in cell and animal models of colon cancer. Nucl Med Biol 2005 1.00
27 In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer. J Nucl Med 2011 1.00
28 The long and short of it: the influence of N-carboxyethyl versusN-carboxymethyl pendant arms on in vitro and in vivo behavior of copper complexes of cross-bridged tetraamine macrocycles. Dalton Trans 2007 1.00
29 In vivo behavior of copper-64-labeled methanephosphonate tetraaza macrocyclic ligands. J Biol Inorg Chem 2002 0.96
30 Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide. Mol Imaging 2009 0.95
31 ⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer. J Med Chem 2014 0.94
32 In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models. Nucl Med Biol 2006 0.94
33 Liposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects. Bioconjug Chem 2010 0.93
34 Macrocyclic diamide ligand systems: potential chelators for 64Cu- and 68Ga-based positron emission tomography imaging agents. Inorg Chem 2009 0.93
35 New cross-bridged cyclam derivative CB-TE1K1P, an improved bifunctional chelator for copper radionuclides. Chem Commun (Camb) 2014 0.91
36 Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastases. J Nucl Med 2009 0.91
37 Monoclonal antibodies for copper-64 PET dosimetry and radioimmunotherapy. Cancer Biol Ther 2011 0.90
38 Very late antigen-4 (α(4)β(1) Integrin) targeted PET imaging of multiple myeloma. PLoS One 2013 0.90
39 Evaluation of copper-64-labeled somatostatin agonists and antagonist in SSTr2-transfected cell lines that are positive and negative for p53: implications for cancer therapy. Nucl Med Biol 2011 0.89
40 Differences in predictors of cervical and breast cancer screening by screening need in uninsured Latino women. Cancer 2007 0.89
41 Nuclear uptake and dosimetry of 64Cu-labeled chelator somatostatin conjugates in an SSTr2-transfected human tumor cell line. J Nucl Med 2007 0.89
42 Production and applications of copper-64 radiopharmaceuticals. Methods Enzymol 2004 0.88
43 Characterization of somatostatin receptor subtype 2 expression in stably transfected A-427 human cancer cells. Mol Imaging 2007 0.88
44 The biodistribution of [153Gd]Gd-labeled magnetic resonance contrast agents in a transgenic mouse model of renal failure differs greatly from control mice. Magn Reson Med 2010 0.87
45 Psychosocial costs of racism to Whites: Understanding patterns among university students. J Couns Psychol 2009 0.87
46 Molecular imaging of very late antigen-4 (α4β1 integrin) in the premetastatic niche. J Nucl Med 2012 0.87
47 Comparison of conjugation strategies of cross-bridged macrocyclic chelators with cetuximab for copper-64 radiolabeling and PET imaging of EGFR in colorectal tumor-bearing mice. Mol Pharm 2014 0.86
48 Radioactivity-synchronized fluorescence enhancement using a radionuclide fluorescence-quenched dye. J Am Chem Soc 2009 0.86
49 Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors. Nucl Med Biol 2012 0.86
50 Online racial discrimination and the protective function of ethnic identity and self-esteem for African American adolescents. Dev Psychol 2012 0.86
51 Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation. Mol Imaging Biol 2012 0.85
52 The role of p53 in the trafficking of copper-64 to tumor cell nuclei. Cancer Biol Ther 2007 0.85
53 64Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for PET imaging: in silico through in vivo studies. J Med Chem 2014 0.84
54 Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals. J Labelled Comp Radiopharm 2013 0.84
55 The effects of print exposure on sentence processing and memory in older adults: Evidence for efficiency and reserve. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2011 0.84
56 Roles of Atox1 and p53 in the trafficking of copper-64 to tumor cell nuclei: implications for cancer therapy. J Biol Inorg Chem 2014 0.83
57 In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas. Cancer Biother Radiopharm 2010 0.83
58 The role of p53 in combination radioimmunotherapy with 64Cu-DOTA-cetuximab and cisplatin in a mouse model of colorectal cancer. J Nucl Med 2013 0.82
59 Application of Collagen-Model Triple-Helical Peptide-Amphiphiles for CD44-Targeted Drug Delivery Systems. J Drug Deliv 2012 0.82
60 Radiometal-labeled somatostatin analogs for applications in cancer imaging and therapy. Methods Mol Biol 2007 0.81
61 In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands. Nucl Med Biol 2004 0.81
62 Rapid and sensitive LC-MS approach to quantify non-radioactive transition metal impurities in metal radionuclides. Chem Commun (Camb) 2013 0.81
63 Developmental changes in sexual prejudice from early to late adolescence: the effects of gender, race, and ideology on different patterns of change. Dev Psychol 2012 0.81
64 A potential Dubin-Johnson syndrome imaging agent: synthesis, biodistribution, and microPET imaging. Mol Imaging 2005 0.80
65 The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow. Pancreas 2015 0.79
66 Synthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes. Dalton Trans 2008 0.79
67 Folate receptor-targeted multimodality imaging of ovarian cancer in a novel syngeneic mouse model. Mol Pharm 2015 0.77
68 Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin αvβ 6. Mol Imaging Biol 2014 0.77
69 Positron emission tomographic imaging of copper 64- and gallium 68-labeled chelator conjugates of the somatostatin agonist tyr3-octreotate. Mol Imaging 2014 0.76
70 Investigation of copper-azamacrocyclic complexes by high-performance liquid chromatography. Biomed Chromatogr 2006 0.76
71 Council-based approaches to intimate partner violence: evidence for distal change in the system response. Am J Community Psychol 2013 0.76
72 Cu(I)-assisted click chemistry strategy for conjugation of non-protected cross-bridged macrocyclic chelators to tumour-targeting peptides. Dalton Trans 2015 0.76
73 Isomeric trimethylene and ethylene pendant-armed cross-bridged tetraazamacrocycles and in vitro/in vivo comparisions of their copper(II) complexes. Inorg Chem 2011 0.76
74 A new vision for the MICoE. J Nucl Med 2010 0.76
75 SNM and AACR announce joint conference. J Nucl Med 2012 0.75
76 State of the science of molecular imaging: 2008. J Nucl Med 2009 0.75
77 Components of a curriculum for molecular imaging scientists. J Nucl Med 2011 0.75
78 Gathering member feedback on SNM name change. J Nucl Med 2011 0.75